ÂÜÀòÂÒÂ×

Clare Bryan is Professor of Innate Immunity at the University of Cambridge in the UK. Clare uses multi-disciplinary approaches to study how Pattern Recognition Receptors signal in response to infectious and non-infectious stimuli. She is internationally recognized for her cutting-edge research to understand the mechanisms of formation, and the composition of, the large signaling complexes triggered by Pattern Recognition Receptor activation. This research focusses on understanding the fundamental mechanisms by which Toll-like receptors and inflammasomes signal to integrate inflammatory processes with a view to developing new treatments for infectious and inflammatory diseases. She has published extensively, is a highly cited scientist, has served on editorial boards (including the Journal of Immunology, The Journal of Biological Chemistry and EMBO) and is a Fellow of the British Pharmacology Society. She has broad interactions with industry including spending time on sabbatical at Genentech and GSK, serving on Biotech scientific advisory boards, consultancy work with pharma and translating her own research in a drug discovery project with Apollo Therapeutics.